Safety and efficacy of cognitive remediation therapy compared with usual treatment for anorexia nervosa: a randomised controlled trial

Shimizu Eiji0 sites30 target enrollmentDecember 3, 2021

Overview

No summary available.

Registry

who.int

Start Date

December 3, 2021

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Sponsor

Shimizu Eiji

•(1\) Patients who meet the diagnostic criteria for anorexia nervosa (including eating disorders that cause emaciation such as avoidance and restrictive food intake) in DSM\-5\.
•2\. BMI between 14\.0 and 18\.5 kg/m2 at the time of consent.
•3\. between 10 and 25 years of age at the time of consent.
•4\. onset of illness less than 3\.5 years
•(5\) Patients who have no coexisting serious psychiatric disorders according to the Brief Structured Interview for Mental Illness (M.I.N.I.).
•(6\) Patients who have received a written consent form of their own free will and that of their parents or guardians after receiving sufficient explanation and understanding of the study.
•7\. be mentally and physically able to attend eight consecutive CRT sessions on a fixed day and time once a week.

•1\. patients with serious physical complications
•2\. patients who require behavioral restrictions due to low body weight
•3\. patients with impending thoughts of death
•4\. patients who have difficulty in understanding assessment and treatment due to intellectual disability
•5\.Patients who have difficulty in understanding assessment and treatment due to poor understanding of Japanese, even considering their age.
•6\.Patients who have repeated antisocial behavior or have difficulty communicating with the researcher.
•7\.Patients who are judged by the investigator or sub\-investigator to be inappropriate for the safe conduct of the study.
•(Patients on stable volume drug therapy will not be excluded.)